UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas

Acta neuropathologica, 2014-11, Vol.128 (5), p.733-741

2014

Volltextzugriff (PDF)

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

Journal of translational medicine, 2019-03, Vol.17 (1), p.96-96, Article 96

2019

Volltextzugriff (PDF)

Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma

EBioMedicine, 2020-02, Vol.52, p.102647-102647, Article 102647

2020

Volltextzugriff (PDF)

H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?

Journal of neuro-oncology, 2013-03, Vol.112 (1), p.67-72

2013

Volltextzugriff (PDF)

Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening

Pharmaceutics, 2024-08, Vol.16 (8), p.1042

2024

Volltextzugriff (PDF)

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

EBioMedicine, 2020-09, Vol.59, p.102962-102962, Article 102962

2020

Volltextzugriff (PDF)

A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”

Acta neuropathologica, 2018-07, Vol.136 (1), p.171-173

2018

Volltextzugriff (PDF)

H3K27-Altered Diffuse Glioma of the Spinal Cord in Adult Patients: A Qualitative Systematic Review and Peculiarity of Radiological Findings

Journal of clinical medicine, 2024-05, Vol.13 (10), p.2972

2024

Volltextzugriff (PDF)

Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity

Brain pathology (Zurich, Switzerland), 2015-07, Vol.25 (4), p.409-417

2015

Volltextzugriff (PDF)

Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential

Journal of Traditional and Complementary Medicine, 2024-01, Vol.14 (1), p.101-108

2024

Volltextzugriff (PDF)

High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord

Acta neuropathologica, 2015-09, Vol.130 (3), p.435-437

2015

Volltextzugriff (PDF)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

Biomarker research, 2023-06, Vol.11 (1), p.56-56, Article 56

2023

Volltextzugriff (PDF)

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (1), p.123-131

2018

Volltextzugriff (PDF)

H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas

American journal of clinical pathology, 2013-03, Vol.139 (3), p.345-349

2013

Volltextzugriff (PDF)

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis

The EMBO journal, 2012-01, Vol.31 (1), p.201-213

2012

Volltextzugriff (PDF)

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

Cancer Immunology, Immunotherapy, 2021-06, Vol.70 (6), p.1781-1788

2021

Volltextzugriff (PDF)

From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks

Molecular oncology, 2024-06

2024

Volltextzugriff (PDF)

Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET

Clinical cancer research, 2021-07, Vol.27 (13), p.3704-3713

2021

Volltextzugriff (PDF)

MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility

Translational oncology, 2017-02, Vol.10 (1), p.70-79

2017

Volltextzugriff (PDF)

The ERICA Score: An MR Imaging–based Visual Scoring System for the Assessment of Entorhinal Cortex Atrophy in Alzheimer Disease

Radiology, 2018-07, Vol.288 (1), p.226-333

2018

Volltextzugriff (PDF)

Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells

Cell death & disease, 2020-08, Vol.11 (8), p.673, Article 673

2020

Volltextzugriff (PDF)

The immediate and short‐term effects of bilateral intrahippocampal depth electrodes on verbal memory

Epilepsia (Copenhagen), 2018-06, Vol.59 (6), p.e78-e84

2018

Volltextzugriff (PDF)

PDGRFB mutation‐associated myofibromatosis: Response to targeted therapy with imatinib

American journal of medical genetics. Part A, 2019-09, Vol.179 (9), p.1895-1897

2019

Volltextzugriff (PDF)

Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment

Journal of cancer research and clinical oncology, 2024-03, Vol.150 (3), p.136-136, Article 136

2024

Volltextzugriff (PDF)

Gliomatosis cerebri: no evidence for a separate brain tumor entity

Acta neuropathologica, 2016-02, Vol.131 (2), p.309-319

2016

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(81)
Berichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma

H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?

Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”

H3K27-Altered Diffuse Glioma of the Spinal Cord in Adult Patients: A Qualitative Systematic Review and Peculiarity of Radiological Findings

Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity

Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential

High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks

Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET

MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility

The ERICA Score: An MR Imaging–based Visual Scoring System for the Assessment of Entorhinal Cortex Atrophy in Alzheimer Disease

Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells

The immediate and short‐term effects of bilateral intrahippocampal depth electrodes on verbal memory

PDGRFB mutation‐associated myofibromatosis: Response to targeted therapy with imatinib

Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment

Gliomatosis cerebri: no evidence for a separate brain tumor entity

Suchergebnisse filtern